SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-031188
Filing Date
2023-11-09
Accepted
2023-11-09 14:26:29
Documents
15
Period of Report
2023-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K inbp20231107_8k.htm   iXBRL 8-K 43089
2 EXHIBIT 99.1 PRESS RELEASE DATED 11 09 2023 ex_592890.htm EX-99.1 40170
7 ibp_logo.jpg GRAPHIC 12671
  Complete submission text file 0001437749-23-031188.txt   226192

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA inbp-20231109.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20231109_def.xml EX-101.DEF 10353
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20231109_lab.xml EX-101.LAB 13836
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20231109_pre.xml EX-101.PRE 10348
9 EXTRACTED XBRL INSTANCE DOCUMENT inbp20231107_8k_htm.xml XML 2312
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-31668 | Film No.: 231391783
SIC: 2834 Pharmaceutical Preparations